NKTR
Nektar Therapeutics
$65.56
-$1.05(-1.58%)
44
Overall
40
Value
50
Tech
42
Quality
Market Cap
$1.20B
Volume
869.46K
52W Range
$7.99 - $109.00
Target Price
$153.25
EPS Estimates Overview
| Current Quarter | $-2.11 | Next Quarter | $-1.74 |
| Current Year | $-9.65 | Next Year | $-11.6 |
| QoQ Growth | +17.5% | YoY Growth | -20.2% |
| 3Y EPS CAGR | +30.9% | Target Price | $153.25 |
| Consensus | Buy | Upside | +133.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NKTR | $65.56 | -1.6% | 869.46K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |